Noticias de dinero

Pfizer RSV vaccine protects older adults over two seasons

Respiratory syncytial virus vial. Manjurul | Istock | Getty Images Pfizer‘s vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday. The shot’s efficacy declined slightly compared with the levels of protection after one RSV season, but the

READ MORE
Noticias de dinero

Pfizer (PFE) Q4 earnings report 2023

Pfizer CEO Albert Bourla talks during a press conference with European Commission President Ursula von der Leyen after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.  John Thys | Reuters Pfizer on Tuesday posted a surprise adjusted fourth-quarter

READ MORE
Noticias de dinero

Pfizer shares tumble, 2024 outlook bleak

NEW YORK CITY: Pfizer issued a disappointing 2024 forecast on Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic. The company, which reported more than $100 billion in revenue in 2022 due to the lift from Covid-19 vaccine and therapeutic sales, sees 2024 revenues of between $58.5

READ MORE
Noticias de dinero

Pfizer nearing 100% Seagen purchase

NEW YORK CITY: Pfizer announced on Tuesday that it expects to complete this week its $43-billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles. “Pfizer and Seagen have now received all required regulatory approvals,” Pfizer said in a news release that reported a key US antitrust waiting period had expired. “Pfizer expects

READ MORE
Noticias de dinero

Pfizer and BioNTech Are Suing Poland Over Its Refusal to Pay for More COVID-19 Vaccines. Are They Also Suing Hungary?

Even by the normal standards of investor-state dispute settlements (ISDS), Pfizer and BioNtech’s lawsuit against the government of Poland for refusing to pay for more unwanted vaccines is especially egregious. Investor State Dispute Settlements, commonly abbreviated to ISDS, rightly have a bad rep, especially among the world’s poorer countries. ISDS clauses in bilateral or collective

READ MORE
Noticias de dinero

Pfizer weight loss pill joins list of obesity drug flops

Sopa Images | Lightrocket | Getty Images Pfizer’s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences.  The drugmaker on Friday said it will stop developing the twice-daily treatment, danuglipron, after obese patients taking the drug

READ MORE
Noticias de dinero

Pfizer to discontinue twice-daily version of weight loss pill

Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study.  The drugmaker observed high rates of adverse side effects, which were mostly mild and gastrointestinal, among patients. A significant

READ MORE